JFNSX
Price
$67.87
Change
-$0.48 (-0.70%)
Updated
Feb 21 closing price
Net Assets
5B
JNGLX
Price
$71.57
Change
-$0.51 (-0.71%)
Updated
Feb 21 closing price
Net Assets
5B
Ad is loading...

JFNSX vs JNGLX

Header iconJFNSX vs JNGLX Comparison
Open Charts JFNSX vs JNGLXBanner chart's image
Janus Henderson Global Life Sciences S
Price$67.87
Change-$0.48 (-0.70%)
VolumeN/A
Net Assets5B
Janus Henderson Global Life Sciences D
Price$71.57
Change-$0.51 (-0.71%)
VolumeN/A
Net Assets5B
JFNSX vs JNGLX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JFNSX vs. JNGLX commentary
Feb 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JFNSX is a Buy and JNGLX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
JFNSX (5B) and JNGLX (5B) have equal amount of cash in the bank . JNGLX pays higher dividends than JFNSX: JNGLX (0.12) vs JFNSX (0.00). JFNSX was incepted earlier than JNGLX: JFNSX (16 years) vs JNGLX (26 years). JFNSX (34.00) and JNGLX (34.00) have comparable annual turnover. JFNSX (2500) and JNGLX (2500) have matching initial minimum investment requirements. JNGLX annual gain was more profitable for investors over the last year : -1.56 vs. JFNSX (-2.19). JNGLX return over 5 years is better than : 18.38 vs. JFNSX (14.93).
JFNSXJNGLXJFNSX / JNGLX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years26 years-
Gain YTD6.1176.17299%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets5B5B100%
Annual Yield % from dividends0.000.12-
Returns for 1 year-2.19-1.56141%
Returns for 3 years14.8516.7189%
Returns for 5 years14.9318.3881%
Returns for 10 years22.6729.5777%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DBOAX24.25N/A
N/A
BNY Mellon Balanced Opportunity A
AIECX18.96N/A
N/A
Invesco EQV International Equity C
MCVIX32.46N/A
N/A
MFS Mid Cap Value I
BRXAX14.06N/A
N/A
MFS Blended Research Intl Eq A
HSXIX8.95N/A
N/A
Hartford Schroders Diversified Em Mkts I